Griffin F M, Mullinax P J
J Exp Med. 1984 Oct 1;160(4):1206-18. doi: 10.1084/jem.160.4.1206.
Macrophage receptors for the third component of complement (C3) are normally immobilized and unable to diffuse within the cell's plasma membrane and, even though they promote avid particle binding, are unable to promote phagocytosis of C3-coated particles. We have previously identified a lymphokine that activates macrophage C3 receptors for phagocytosis and have found that it acts by freeing the receptors so that they can diffuse within the macrophage plasma membrane. It seemed likely to us that the initial lymphokine-macrophage interaction would occur at the macrophage surface, perhaps via a specific lymphokine receptor. Since the binding of many ligands to cells is mediated by cell surface glycoproteins, we examined the protein and sugar requirements for murine peritoneal macrophages to respond to the lymphokine. Macrophages treated with the neutral protease Dispase lost the ability to respond to the lymphokine, and inclusion of L-fucose in the incubation medium containing lymphokine and macrophages inhibited markedly the macrophages' response to the lymphokine, suggesting that the lymphokine exerts its effects by first binding to fucose residues on a glycoprotein receptor on the macrophage surface. Further evidence for the essential role of macrophage surface fucose was obtained by demonstrating that pretreatment of macrophages with either fucosidase or gorse lectin, a fucose-binding lectin, strikingly disabled the cells from responding to the lymphokine. All treatments that prevented lymphokine activation of macrophage C3 receptors for phagocytosis also prevented lymphokine-induced C3 receptor mobility. These results strongly suggest that the lymphokine binds to a fucose-bearing macrophage surface glycoprotein, perhaps a specific lymphokine receptor. They also strengthen our hypothesis that, for a receptor to be able to promote phagocytosis, it must be able to diffuse within the macrophage plasma membrane.
补体第三成分(C3)的巨噬细胞受体通常是固定的,无法在细胞质膜内扩散,并且即使它们能促进颗粒的紧密结合,也无法促进对C3包被颗粒的吞噬作用。我们之前鉴定出一种能激活巨噬细胞C3受体以进行吞噬作用的淋巴因子,并且发现它的作用方式是使这些受体得以释放,从而能够在巨噬细胞质膜内扩散。在我们看来,最初的淋巴因子 - 巨噬细胞相互作用可能发生在巨噬细胞表面,或许是通过一种特定的淋巴因子受体。由于许多配体与细胞的结合是由细胞表面糖蛋白介导的,我们研究了小鼠腹腔巨噬细胞对该淋巴因子产生反应所需的蛋白质和糖类条件。用中性蛋白酶Dispase处理的巨噬细胞失去了对淋巴因子产生反应的能力,并且在含有淋巴因子和巨噬细胞的孵育培养基中加入L - 岩藻糖显著抑制了巨噬细胞对淋巴因子的反应,这表明淋巴因子首先通过与巨噬细胞表面糖蛋白受体上的岩藻糖残基结合来发挥其作用。通过证明用岩藻糖苷酶或荆豆凝集素(一种结合岩藻糖的凝集素)对巨噬细胞进行预处理会显著使细胞无法对淋巴因子产生反应,从而获得了关于巨噬细胞表面岩藻糖重要作用的进一步证据。所有阻止淋巴因子激活巨噬细胞C3受体进行吞噬作用的处理也都阻止了淋巴因子诱导的C3受体移动。这些结果强烈表明淋巴因子与带有岩藻糖的巨噬细胞表面糖蛋白结合,可能是一种特定的淋巴因子受体。它们还强化了我们的假设,即对于一个受体要能够促进吞噬作用,它必须能够在巨噬细胞质膜内扩散。